替加环素
医学
内科学
鲍曼不动杆菌
荟萃分析
观察研究
置信区间
不动杆菌
系统回顾
梅德林
抗生素
微生物学
生物
铜绿假单胞菌
遗传学
细菌
生物化学
作者
Fatemeh Sodeifian,Moein Zangiabadian,Erfan Arabpour,Naghmeh Kian,Fartous Yazarlou,Mehdi Goudarzi,Rosella Centis,Zahra Sadat Seghatoleslami,Mahdis Chahar Kameh,Bardia Danaei,Hossein Goudarzi,Mohammad Javad Nasiri,Giovanni Sotgiu,Giovanni Battista Migliori
标识
DOI:10.1089/mdr.2022.0248
摘要
Introduction: The use of tigecycline (TG) for the treatment of Acinetobacter baumannii is controversial. In this systematic review and meta-analysis, we aimed to better explore the safety and efficacy of TG for the treatment of multi drug-resistant (MDR) Acinetobacter. Methods: We searched PubMed/MEDLINE, Scopus, Cochrane Central, and Web of Science to identify studies reporting the clinical and microbiological efficacy and safety of regimens containing TG in patients with drug susceptibility testing (DST)-confirmed MDR A. baumannii, published until December 30, 2022. Observational studies were included if they reported clinical and microbiological efficacy of TG-based regimens. The Newcastle-Ottawa Scale (NOS) and Joana Briggs Institute (JBI) critical appraisal tool were used to assess the quality of included studies. Results: There were 30 observational studies, of which 19 studies were cohort and 11 studies were single group studies. Pooled clinical response and failure rates in the TG-containing regimens group were 58.1 (95% confidence interval [CI] 49.2-66.6) and 40.2 (95% CI 31.1-50.0), respectively. The pooled microbiological response rate was 32.1 (95% CI 19.8-47.5), and the pooled all-cause mortality rate was 41.1 (95% CI 34.1-48.4). Pooled clinical response and failure rates in the colistin-based regimens group were 52.7 (42.7-62.5) and 43.1 (33.1-53.8), respectively. The pooled microbiological response rate was 42.9 (16.2-74.5), and the pooled all-cause mortality rate was 34.3 (26.1-43.5). Conclusions: According to our results, the efficacy of the TG-based regimen is the same as other antibiotics. However, our study showed a high mortality rate and a lower rate of microbiological eradication for TG compared with colistin-based regimen. Therefore, our study does not recommend it for the treatment of MDR A. baumannii. However, this was a prevalence meta-analysis of observational studies, and for better conclusion experimental studies are required.
科研通智能强力驱动
Strongly Powered by AbleSci AI